PHAT - Phathom Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

PHAT is currently covered by 5 analysts with an average price target of $23. This is a potential upside of $11.95 (108.14%) from yesterday's end of day stock price of $11.05.

Phathom Pharmaceuticals's activity chart (see below) currently has 12 price targets and 32 ratings on display. The stock rating distribution of PHAT is 17.39% HOLD and 82.61% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 22.92% with an average time for these price targets to be met of 40.25 days.

Highest price target for PHAT is $26, Lowest price target is $10, average price target is $23.

Most recent stock forecast was given by JOSEPH STRINGER from NEEDHAM on 07-Mar-2024.

Currently out of the existing stock ratings of PHAT, 4 are a HOLD (17.39%), 19 are a BUY (82.61%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

26

$14.95 (135.29%)

26

22 days ago

0/13 (0%)

$16.91 (186.03%)

Hold

10

$-1.05 (-9.50%)

4 months 26 days ago

5/6 (83.33%)

$1.27 (14.55%)

34

Buy

15

$3.95 (35.75%)

22

1 years 28 days ago

1/6 (16.67%)

$5.99 (66.48%)

152

Buy

30

$18.95 (171.49%)

35

1 years 28 days ago

0/4 (0%)

$20.99 (232.96%)

Buy

62

$52.74 (569.55%)

50

2 years 5 months 11 days ago

0/2 (0%)

$22.82 (77.64%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is PHAT (Phathom Pharmaceuticals) average time for price targets to be met?

On average it took 40.25 days on average for the stock forecasts to be realized with a an average price target met ratio 22.92

Which analyst has the current highest performing score on PHAT (Phathom Pharmaceuticals) with a proven track record?

PAUL CHOI

Which analyst has the current lower performing score on PHAT (Phathom Pharmaceuticals) with a proven track record?

UMER RAFFAT

Which analyst has the most public recommendations on PHAT (Phathom Pharmaceuticals)?

Paul Choi has 15 price targets and 9 ratings on PHAT

Which analyst is the currently most bullish on PHAT (Phathom Pharmaceuticals)?

Prakhar Agrawal with highest potential upside - $52.74

Which analyst is the currently most reserved on PHAT (Phathom Pharmaceuticals)?

Paul Choi with lowest potential downside - -$1.05

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?